GlobalData's clinical trial report, "Fungemia Global Clinical Trials Review, H2, 2012" provides data on the Fungemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fungemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fungemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Fungemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Fungemia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Fungemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Fungemia 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Fungemia Therapeutics Clinical Trials 26
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
BIOWEST THERAPEUTICS Inc 29
Clinical Trial Overview of BIOWEST THERAPEUTICS Inc 29
Fovea Pharmaceuticals SA 30
Clinical Trial Overview of Fovea Pharmaceuticals SA 30
Astellas Pharma Inc. 31
Clinical Trial Overview of Astellas Pharma Inc. 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
University of Pittsburgh 32
Clinical Trial Overview of University of Pittsburgh 32
Taipei Medical University WanFang Hospital 33
Clinical Trial Overview of Taipei Medical University WanFang Hospital 33
Chinese PLA General Hospital 34
Clinical Trial Overview of Chinese PLA General Hospital 34
Peking University 35
Clinical Trial Overview of Peking University 35
Rennes University Hospital 36
Clinical Trial Overview of Rennes University Hospital 36
Rambam Health Care Campus 37
Clinical Trial Overview of Rambam Health Care Campus 37
The Medical University of Graz 38
Clinical Trial Overview of The Medical University of Graz 38
Five Key Clinical Profiles 39
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 63
List of Tables
List of Tables
Fungemia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 6
Fungemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Fungemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Fungemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 9
Fungemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10
Fungemia Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Fungemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 12
Fungemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13
Fungemia Global Clinical Trials Review, H2, 2012 published by GlobalData in August 15, 2012. This report consists of Pages: 63 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
